IRIS
TARAMASSO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.733
AS - Asia 2.093
NA - Nord America 1.935
Continente sconosciuto - Info sul continente non disponibili 406
SA - Sud America 164
AF - Africa 40
OC - Oceania 4
Totale 17.375
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.417
US - Stati Uniti d'America 1.796
SG - Singapore 741
CN - Cina 498
VN - Vietnam 398
BD - Bangladesh 263
FR - Francia 111
BR - Brasile 96
CA - Canada 69
HK - Hong Kong 53
FI - Finlandia 48
DE - Germania 43
MX - Messico 28
GB - Regno Unito 27
AR - Argentina 26
JP - Giappone 26
IQ - Iraq 22
IN - India 13
NL - Olanda 13
ID - Indonesia 12
EC - Ecuador 11
PH - Filippine 11
ZA - Sudafrica 10
CO - Colombia 9
CL - Cile 8
PK - Pakistan 8
JM - Giamaica 7
CH - Svizzera 6
PY - Paraguay 6
SA - Arabia Saudita 6
SE - Svezia 6
UA - Ucraina 6
DZ - Algeria 5
ES - Italia 5
GT - Guatemala 5
IE - Irlanda 5
RU - Federazione Russa 5
TN - Tunisia 5
TR - Turchia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EG - Egitto 4
ET - Etiopia 4
MA - Marocco 4
NI - Nicaragua 4
PE - Perù 4
PL - Polonia 4
PS - Palestinian Territory 4
RO - Romania 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CR - Costa Rica 3
GA - Gabon 3
GR - Grecia 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
MD - Moldavia 3
NP - Nepal 3
PT - Portogallo 3
RS - Serbia 3
SY - Repubblica araba siriana 3
VE - Venezuela 3
AG - Antigua e Barbuda 2
AT - Austria 2
BE - Belgio 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
MT - Malta 2
PR - Porto Rico 2
SI - Slovenia 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 16.967
Salva come PNG Salva come JPEG
Città #
Genova 5.419
Genoa 4.380
Rapallo 1.163
Vado Ligure 1.143
San Jose 406
Singapore 347
Ashburn 267
Ho Chi Minh City 116
Hanoi 101
Lauterbourg 99
Beijing 98
New York 90
Council Bluffs 77
Hong Kong 50
Helsinki 45
Los Angeles 45
Bordighera 44
Santa Clara 41
Frankfurt am Main 32
Buffalo 26
Rome 26
Dallas 22
St Louis 21
Tokyo 21
Boardman 20
Milan 20
Haiphong 19
Chicago 17
Orem 16
Da Nang 15
Mexico City 15
Las Vegas 14
Houston 13
Toronto 13
Florence 12
Montreal 12
Tianjin 12
Atlanta 11
Baghdad 11
Washington 11
Biên Hòa 10
London 10
Brooklyn 9
Palermo 9
Phoenix 9
São Paulo 9
Turin 9
Denver 8
Naples 8
Bari 7
New Orleans 7
Can Tho 6
Philadelphia 6
Raleigh 6
Rio de Janeiro 6
San Francisco 6
Amsterdam 5
Asunción 5
Cardiff 5
City of London 5
Dhaka 5
Guangzhou 5
Guatemala City 5
Jakarta 5
Johannesburg 5
Milwaukee 5
Ninh Bình 5
Quảng Ngãi 5
Santiago 5
Stockholm 5
The Bronx 5
Zurich 5
Addis Ababa 4
Birmingham 4
Bắc Ninh 4
Calgary 4
Detroit 4
Fort Wayne 4
Guayaquil 4
Kansas City 4
Kingston 4
Kyiv 4
Louisville 4
Managua 4
Miami 4
Miano 4
Queens 4
Rochester 4
San Salvador 4
Shanghai 4
Trenton 4
Verona 4
Amman 3
Ankara 3
Auburn 3
Belgrade 3
Bogotá 3
Bologna 3
Bridgetown 3
Bắc Giang 3
Totale 14.619
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 278
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? 269
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 234
Bloodstream infections in patients living with HIV in the modern cART era 229
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 225
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 210
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 202
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 200
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 196
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 194
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
AUMENTO DEGLI INDICI DI CITOLISI EPATICA NEI SOGGETTI CON INFEZIONE DA HIV CHE AVVIANO LA PRIMA LINEA DI TRATTAMENTO ANTIRETROVIRALE: STUDIO OSSERVAZIONALE DI COORTE 192
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 182
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 181
Bloodstream infections in critically ill patients with COVID-19 180
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 177
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 177
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 173
Bedaquiline: A new hope for shorter and better anti-tuberculosis regimens 173
Weight gain: A possible side effect of all antiretrovirals 166
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy 166
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 165
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 162
Will new antimicrobials overcome resistance among Gram-negatives? 159
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 159
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 159
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients 155
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 153
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 150
Is it time to re-think the use of etravirine in patients with available genotypic resistance test? 148
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy? 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
Factors associated with hospital admission for COVID-19 in HIV patients 146
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing 143
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 142
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 142
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 142
Pineal Germinoma in a Child with Interferon-γ Receptor 1 Deficiency. Case Report and Literature Review 142
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 141
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 141
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? 139
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 137
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes 136
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 136
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 136
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 135
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 134
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 133
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 132
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 132
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? 128
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 126
Onychomadesis in a male patient with secondary syphilis 125
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 125
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 125
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 125
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 125
Treatment of hepatitis C virus genotype 4 in the DAA era 124
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 123
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 122
Injectable Antiretroviral Drugs: Back to the Future 122
Bloodstream infections in HIV-infected patients 121
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations. Results from a large observational study 121
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 120
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 120
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia 120
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. 120
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 117
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients 115
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency 114
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 114
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 112
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 110
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 110
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment 109
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 108
Co-infezione HIV/HCV e malattia renale: un binomio “scindibile” 107
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 106
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 105
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 105
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 105
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 104
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 104
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study 103
Aspetti medico sanitari, area infettivologica. In: Being Positive Strategie e Linguaggi per la comunicazione dell'HIV 102
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 101
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 101
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients 100
CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders 100
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 99
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 97
Duration of isolation and precautions in immunocompromised patients with COVID-19 96
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 95
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 95
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 95
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 95
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 94
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 94
Totale 14.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.510
article - articoli 61.358
book - libri 0
conference - conferenze 1.339
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 322
Totale 126.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.201 48 39 59 138 51 98 57 270 105 126 50 160
2022/20231.434 119 115 11 130 175 195 64 105 209 109 178 24
2023/2024922 39 94 13 111 68 146 71 64 43 25 98 150
2024/20252.972 91 200 91 188 377 282 353 521 120 149 280 320
2025/20265.796 613 168 464 386 660 379 801 275 453 624 460 513
2026/2027573 573 0 0 0 0 0 0 0 0 0 0 0
Totale 17.375